Pulse 4 Pulse
Pulse 4 Pulse is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Pulse 4 Pulse.
Pulse 4 Pulse is a company.
Key people at Pulse 4 Pulse.
Pulse4Pulse is a healthcare services company based in Waterbury, Connecticut, specializing in onsite diagnostic testing of the cardiovascular and autonomic nervous system to enable early detection of chronic diseases in asymptomatic patients.[1][2][6] It offers an all-in-one service—including FDA-cleared portable medical devices, onsite certified medical technicians, immediate physician reports, and full-service billing—targeting physicians' practices to shift healthcare from reactive to proactive, focusing on the microvascular system for personalized early interventions.[1][2][3][8] With under 25 employees and revenue below $5 million, it has raised limited funding (under $5M total) and emphasizes Medicare-approved tests that 60% of patients qualify for, up to three times yearly, to improve patient care, diagnose complex symptoms, and boost treatment compliance.[1][6]
Pulse4Pulse LLC was incorporated on July 12, 2017, as a limited liability company in Connecticut, with Ms. Krista Mowad serving as President and principal contact.[4] The company emerged to address gaps in proactive healthcare, pioneering diagnostic testing for the microvascular system to detect issues before they escalate, driven by a belief in Early Detection Medicine (EDM) as key to successful treatment.[1][8] Early traction includes building an onsite service model with portable tech and billing support, evolving from a medical billing focus to comprehensive diagnostics, as reflected in its BBB profile and operational setup by 2020.[4] Employee reviews highlight rapid growth, with roles like certified medical assistants noting easy training, independent workflows, and supportive remote management amid high-pressure events.[5]
Pulse4Pulse rides the trend toward preventive healthcare and Early Detection Medicine, leveraging portable, FDA-cleared diagnostics amid rising demand for non-invasive chronic disease screening in primary care.[1][2][8] Timing aligns with post-pandemic emphasis on proactive models, microvascular insights for conditions like diabetes or hypertension, and Medicare reimbursement incentives that favor early interventions over costly late-stage treatments.[6] Market forces include aging populations, value-based care shifts, and tech portability enabling onsite use in small practices; it influences the ecosystem by empowering physicians with actionable data, reducing invasive procedures, and standardizing asymptomatic screenings as envisioned in its mission.[1][8]
Pulse4Pulse is positioned to expand its onsite model as preventive diagnostics gain traction, potentially scaling through partnerships with larger networks or tech integrations for broader asymptomatic screening adoption.[1][2] Trends like AI-enhanced reporting, telehealth synergies, and expanded insurance coverage for microvascular tests could accelerate growth, while workforce scaling (e.g., more technicians at ~$22/hour) supports demand.[5][7] Its influence may evolve from niche provider to standard in physician practices, reinforcing the paradigm shift to EDM—empowering early insights that started with its microvascular focus.[8]
Key people at Pulse 4 Pulse.
